Critical to understanding the pathogenesis of disseminated candi- diasis is elucidation of the events of escape of Candida from the intravascular compartment and its penetration through vessel walls during invasion of target organs. This process occurs in a milieu rich in circulating humoral and cellular elements and across the boundary of the vascular endothelial cells. During the last grant period, utilizing a model of the vascular compartment-endothelial cell interface consisting of human vascular endothelial cells in tissue culture, we found evidence for a ligand-dependent interaction in adherence of Candida to endothelium, made a polyclonal antiserum that blocks adherence, and showed, for the first time, a protective role of leukocytes for endothelium during Candida tissue penetration. Additionally, we developed an ELISA for quantifying endothelial cell adherence, an elutriator system for adding additional dimensions to monitoring neutrophil and endothelial cell secretory physiological responses, and methods to focus on facets of Candida physiology such as cell wall composition, cell morphology, and secretory products likely to be important in adherence and penetration of endothelium. Using this background knowledge and the newer methods we developed during the previous funding period, we will characterize the nature of the adhesin ligand using immunoprecipitation of cell wall adhesins with antiserum that blocks adherence and with biochemically extracted cell wall constituents, elucidate mechanisms of Candida penetration of endothelium with selected cerulenin resistant, germ tube negative, and protease negative mutants, determine mechanisms by which neutrophils protect endothelium from Candida damage, characterize chemotactic factors secreted by endothelium, and determine whether endothelial cells enhance circulating neutrophil-Candida phagocytosis and killing through secretion of cytokines and/or contiguous contact with neutrophils.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI019990-08
Application #
3129452
Study Section
Bacteriology and Mycology Subcommittee 2 (BM)
Project Start
1984-09-01
Project End
1993-07-31
Budget Start
1992-08-01
Budget End
1993-07-31
Support Year
8
Fiscal Year
1992
Total Cost
Indirect Cost
City
Torrance
State
CA
Country
United States
Zip Code
90502
Yeaman, Michael R; Filler, Scott G; Schmidt, Clint S et al. (2014) Applying Convergent Immunity to Innovative Vaccines Targeting Staphylococcus aureus. Front Immunol 5:463
Fu, Yue; Phan, Quynh T; Luo, Guanpingsheng et al. (2013) Investigation of the function of Candida albicans Als3 by heterologous expression in Candida glabrata. Infect Immun 81:2528-35
Ibrahim, Ashraf S; Luo, Guanpingsheng; Gebremariam, Teclegiorgis et al. (2013) NDV-3 protects mice from vulvovaginal candidiasis through T- and B-cell immune response. Vaccine 31:5549-56
Schmidt, Clint S; White, C Jo; Ibrahim, Ashraf S et al. (2012) NDV-3, a recombinant alum-adjuvanted vaccine for Candida and Staphylococcus aureus, is safe and immunogenic in healthy adults. Vaccine 30:7594-600
Luo, Guanpingsheng; Ibrahim, Ashraf S; French, Samuel W et al. (2011) Active and passive immunization with rHyr1p-N protects mice against hematogenously disseminated candidiasis. PLoS One 6:e25909
Liu, Yaoping; Mittal, Rahul; Solis, Norma V et al. (2011) Mechanisms of Candida albicans trafficking to the brain. PLoS Pathog 7:e1002305
Moreno-Ruiz, Emilia; Galán-Díez, Marta; Zhu, Weidong et al. (2009) Candida albicans internalization by host cells is mediated by a clathrin-dependent mechanism. Cell Microbiol 11:1179-89
Park, Hyunsook; Liu, Yaoping; Solis, Norma et al. (2009) Transcriptional responses of candida albicans to epithelial and endothelial cells. Eukaryot Cell 8:1498-510
Reed, Caitlin; Bryant, Richard; Ibrahim, Ashraf S et al. (2008) Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis. Clin Infect Dis 47:364-71
Spellberg, Brad; Ibrahim, Ashraf S; Lin, Lin et al. (2008) Antibody titer threshold predicts anti-candidal vaccine efficacy even though the mechanism of protection is induction of cell-mediated immunity. J Infect Dis 197:967-71

Showing the most recent 10 out of 54 publications